We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Scientific Project Support

Genentech is committed to the pursuit of groundbreaking science to discover and develop breakthrough medicines for people with serious and life-threatening diseases. We envision a world where all individuals can experience their full potential for health and wellbeing, and a future of science and healthcare that is more diverse, equitable, and inclusive.

Important Notice

Due to our 2021 year-end close process, the Genentech Funding Request System will stop accepting Fellowship, Scientific Project, Healthcare-Related and Philanthropic Charitable Support requests at 12:00AM PT, Wednesday, November 24 and will reopen for requests on Monday, January 3, 2022.

This temporary closure affects Healthcare-Related Charitable support, Scientific Project Support, Fellowship and Philanthropic Support requests. Independent Medical Education will continue to be accepted during this time.

It is important to note the Genentech Funding Request System cannot accept requests less than 60 days prior to the event/program start date. Therefore, if you plan to submit a charitable contribution request for an event or program occurring before March 4, 2022, please submit your request no later than November 23, to ensure consideration.

Pending requests with event/program dates beginning in January 2022 or beyond may receive final decisions in the new year.

Important Notice

Genentech is committed to advancing health equity, supporting diversity in STEM and medical career pathways, supporting patients, scientific exchange, and our local communities.

While we are no longer accepting unsolicited grant submissions for the 2021 funding year, we remain committed to these values and funding priorities. We invite you to periodically review our website for future funding opportunities.

If you have been invited to apply for funding, or are an existing grantee with specific questions about current funding and reporting, please reach out to your Genentech contact to address your questions. If you are unsure of who to contact with questions, please email [email protected] and you will be directed to the appropriate contact.

Important Notice

Genentech is committed to supporting our existing grantees during the evolving coronavirus (COVID-19) pandemic. We understand that grantees will have their own challenges in adapting to rapidly changing events, and we will work to accommodate needs for the programs funded by Genentech.

If you are an existing grantee, please contact your Genentech representative with questions or to let us know if your program or event will be cancelled or postponed. If you are unsure of who to contact, please email [email protected] and we will direct you to the appropriate person.

For more information on Genentech’s relief and recovery efforts during the COVID-19 pandemic, please visit our COVID-19 response page.

Scientific Project Support provides funding for general research, translational research, other research or development projects, and/or other initiatives of research organizations, labs, and academic institutions. As part of our company-wide commitment to ensuring a healthier future for all patients, we prioritize projects that build a more fair and just healthcare system in the following areas:

  • Inclusive research: Reducing barriers to participation in clinical trials so healthcare solutions are designed for all patients
  • Equity in care: Ensuring all patients have access to high quality care
  • Future life sciences workforce: Create sustainable pathways into the life sciences for underrepresented groups, particularly low-income students of color

Research collaborations, clinical trials, and associated correlative research involving or undertaken in relation to Genentech or Roche products (whether investigational and/or approved for other uses) are excluded from this type of support. For information regarding these types of programs, please refer to our pipeline.

Decision Making

Requests must be submitted at least 90 days prior to the project/program start date. Decisions are made on a case-by-case basis; Genentech will be in touch regarding your proposal and you will receive a decision prior to the project/program start date.

Letter of Agreement (LOA)

All grants must abide by the terms in the Genentech Letter of Agreement (LOA), which is issued to an authorized signer of your organization once the application is approved. You must agree to the terms of the LOA before any funding is issued. If you have any questions on the agreement terms, please contact us at (877) 313-5778.

How to Submit a Funding Request Tip Sheet

Note: The funding application site does not support IE8 or earlier

*We are no longer accepting unsolicited grant submissions for the 2021 funding year.

*We are no longer accepting unsolicited grant submissions for the 2021 funding year.